Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neoplasms × Nivolumab × Clear all

Phase

Phase 1 31 Phase 1/2 24 Phase 2 20 Phase 3 3 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 3 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Carcinoma 1 Neoplasms 1 Malignant Ascites 1 Lung Neoplasms 1 Glioma 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Exercise 70 Blood Specimen Collection 41 Standard of Care 40 Methods 30 Therapeutics 24 Surveys and Questionnaires 24 Educational Status 24 Control Groups 19 Cognitive Behavioral Therapy 19 Interviews as Topic 16 Acupuncture Therapy 14 Music Therapy 13 Early Intervention, Educational 13 Biopsy 13 Palliative Care 11 Magnetic Resonance Spectroscopy 11 Resistance Training 10 Radiotherapy 9 Radiosurgery 9 Yoga 8 Practice Guidelines as Topic 8 Patient Navigation 8 Ultraviolet Therapy 7 Psychiatric Rehabilitation 7 Physical Therapy Modalities 7 Nutritional Status 7 Nutrition Assessment 7 Geriatric Assessment 7 Dietary Supplements 7 Dexamethasone 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡